Restrictive Eligibility Limits Access to Newer Therapies in Non–Small-Cell Lung Cancer: The Implications of Eastern Cooperative Oncology Group 4599
Authors:
- Eric ShermanESEric Sherman
- Corey J. LangerCLCorey J. Langer
- 1 March 2008
- journal article
- Published by Elsevier in Clinical Lung Cancer
- Vol. 9 (2) , 102-105
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Overview of the Current Status of Human Epidermal Growth Factor Receptor Inhibitors in Lung CancerClinical Lung Cancer, 2004
- New targeted treatments in lung cancer — overview of clinical trialsLung Cancer, 2004
- Anti-Vascular Endothelial Growth Factor Monoclonals in Non-Small Cell Lung CancerClinical Cancer Research, 2004
- Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung CancerJournal of Clinical Oncology, 2004
- Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1Journal of Clinical Oncology, 2004
- Emerging role of epidermal growth factor receptor inhibition in therapy for advanced malignancy: focus on NSCLCInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Phase III Randomized Trial Comparing Three Platinum-Based Doublets in Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2002
- Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 Is Generally Well-Tolerated and Has Activity in Non–Small-Cell Lung Cancer and Other Solid Tumors: Results of a Phase I TrialJournal of Clinical Oncology, 2002
- Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung CancerNew England Journal of Medicine, 2002
- Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.Journal of Clinical Oncology, 1994